Clinical findings in a carrier of a new mutation in the choroideremia gene

被引:26
|
作者
Potter, MJ
Wong, E
Szabo, SM
McTaggart, KE
机构
[1] Univ British Columbia, Dept Ophthalmol & Visual Sci, Vancouver, BC V5Z 3N9, Canada
[2] Univ Western Ontario, Fac Med, London, ON, Canada
[3] Univ Alberta, Dept Ophthalmol, Ocular Genet Lab, Edmonton, AB T6G 2M7, Canada
关键词
D O I
10.1016/j.ophtha.2004.04.028
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Objective: To describe the clinical and molecular findings of a female carrier of a new mutation in the choroideremia (CHM) gene. Design: Single interventional case report. Methods: A 27-year-old woman was seen with mild difficulties with dark adaptation and a history of a retinal degeneration in her father and choroideremia in 3 male paternal first cousins. Visual acuity measurements, peripheral and color vision tests, electroretinography (ERG), Goldmann visual fields, fluorescein angiogram, computed tomography scan, and DNA analysis were performed. Main Outcome Measures: (1) Visual fields, (2) fluorescein angiography, and (3) DNA analysis. Results: Visual acuity decreased from 20/30 to 10/200 in the right eye abruptly over 2 months, then remained stable over 2 years of follow-up and remained 20/25 in the left eye. Goldmann visual fields showed development of a central scotoma in the right eye concurrent with the rapid decline. A small amount of subretinal hemorrhage was visible on dilated fundus examination at that time, but definite leakage was not evident on fluorescein angiography; afterwards, a choroidal neovascular membrane (CNV) was suspected. The ERG was normal. DNA analysis revealed that the patient was heterozygous for a previously undescribed substitution mutation at the 3'-splice site of intron 6 of the CHM gene (850-1 G to C), confirmed by mRNA analysis with reverse transcriptase polymerase chain reaction. Conclusions: Severe visual acuity loss rarely occurs in female carriers of choroideremia mutations. The diagnosis should be considered in patients with a suitable family history and fundus findings. Physicians should consider the possibility of CNV development in such patients, which may be a response to abnormal retinal pigment epithelium. Recognition of this new mutation may help identify patients who could benefit from current and future treatments to protect against vision loss. (C) 2004 by the American Academy of Ophthalmology.
引用
收藏
页码:1905 / 1909
页数:5
相关论文
共 50 条
  • [21] A NEW (OLD) DELETION IN THE CHOROIDEREMIA GENE
    PASCAL, O
    DONNELLY, P
    FOUANON, C
    HERBERT, M
    LEROUX, MG
    MOISAN, JP
    HUMAN MOLECULAR GENETICS, 1993, 2 (09) : 1489 - 1489
  • [22] Presentation of a new mutation in FMF and evaluating the frequency of distribution of the MEFV gene mutation in our region with clinical findings
    Arpaci, Abdullah
    Dogan, Serdar
    Erdogan, Hazal Fatma
    El, Cigdem
    Cura, Sibel Elmacioglu
    MOLECULAR BIOLOGY REPORTS, 2021, 48 (03) : 2025 - 2033
  • [23] Presentation of a new mutation in FMF and evaluating the frequency of distribution of the MEFV gene mutation in our region with clinical findings
    Abdullah Arpacı
    Serdar Doğan
    Hazal Fatma Erdoğan
    Çiğdem El
    Sibel Elmacıoğlu Cura
    Molecular Biology Reports, 2021, 48 : 2025 - 2033
  • [24] A 3-base pair insertional mutation in the choroideremia gene
    Nesslinger, N
    Horrocks, S
    Ray, PN
    Strasberg, P
    MacDonald, IM
    HUMAN MUTATION, 1998, : S38 - S39
  • [25] MUTATION SPECTRUM IN THE CHM GENE OF DANISH AND SWEDISH CHOROIDEREMIA PATIENTS
    VANBOKHOVEN, H
    SCHWARTZ, M
    ANDREASSON, S
    VANDENHURK, JAJM
    BOGERD, L
    JAY, M
    RUTHER, K
    JAY, B
    PAWLOWITZKI, IH
    SANKILA, EM
    WRIGHT, A
    ROPERS, HH
    ROSENBERG, T
    CREMERS, FPM
    HUMAN MOLECULAR GENETICS, 1994, 3 (07) : 1047 - 1051
  • [26] Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial
    MacLaren, Robert E.
    Groppe, Markus
    Barnard, Alun R.
    Cottriall, Charles L.
    Tolmachova, Tanya
    Seymour, Len
    Clark, K. Reed
    During, Matthew J.
    Cremers, Frans P. M.
    Black, Graeme C. M.
    Lotery, Andrew J.
    Downes, Susan M.
    Webster, Andrew R.
    Seabra, Miguel C.
    LANCET, 2014, 383 (9923): : 1129 - 1137
  • [27] Variation of Clinical Findings in Choroideremia Carriers - From normal to severe
    Kellner, Ulrich
    Stoehr, Heidi
    Kellner, Simone
    Weinitz, Silke
    Farmand, Ghazaleh
    Weber, Bernhard H. F.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [28] A new KCNQ2 mutation and clinical findings
    Gumus, A. Aydin
    Bilgic, D. Gun
    Berdeli, A.
    Genis, E.
    Cam, S.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1860 - 1860
  • [29] A HISTOPATHOLOGIC STUDY OF A CHOROIDEREMIA CARRIER
    FLANNERY, JG
    BIRD, AC
    FARBER, DB
    WELEBER, RG
    BOK, D
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1990, 31 (02) : 229 - 236
  • [30] STRUCTURE OF THE PUTATIVE CHOROIDEREMIA GENE AND MUTATION SPECTRUM IN PATIENTS WITH TAPETOCHOROIDAL DEGENERATION
    CREMERS, F
    BERGER, W
    RUTHER, K
    BACH, I
    MOLLOY, K
    WIERINGA, B
    ZRENNER, E
    ROPERS, HH
    VANDERHURK, J
    VANDERPOL, D
    AMERICAN JOURNAL OF HUMAN GENETICS, 1991, 49 (04) : 3 - 3